Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

968
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
968
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Biosynthesis in Bacteria01:24

Biosynthesis in Bacteria

806
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
806
Antibiotic Selection00:57

Antibiotic Selection

60.7K
Overview
60.7K
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

3.2K
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mucin-derived sugars act as metabolic brakes controlling growth initiation in <i>Akkermansia muciniphila</i>.

Gut microbes·2026
Same author

Revised complete genome sequences of <i>Limosilactobacillus reuteri</i> DSM 20016<sup>T</sup> and ATCC PTA-6475 and confirmation of an intragenic macrosatellite in adhesin gene <i>cmbA</i>.

Microbiology spectrum·2026
Same author

Medication Abortion Failure in a Patient With Class III Obesity and Twin Gestation: A Case Report.

Cureus·2026
Same author

<i>Limosilactobacillus reuteri</i> promotes melatonin release from human intestinal organoids via 5'ectonucleotidase activity.

Gut microbes·2026
Same author

CRISPR-AsCas12a and dAsCas12a-Mediated Gene Knockout and Knockdown in Clostridioides difficile.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

An In Vitro Model for Studying Interactions Between Gastrointestinal Microbes and Planktonic and Sessile Clostridioides difficile Populations.

Methods in molecular biology (Clifton, N.J.)·2026

Related Experiment Video

Updated: Feb 25, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.3K

Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis.

Jennifer K Spinler1,2, Jennifer Auchtung3, Aaron Brown4,2

  • 1Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA spinler@bcm.edu.

Infection and Immunity
|August 2, 2017
PubMed
Summary

Lactobacillus reuteri produces the antimicrobial reuterin from glycerol, effectively preventing Clostridium difficile infection recurrence. This probiotic approach enhances microbiome function against C. difficile, offering a novel therapeutic strategy.

Keywords:
Clostridium difficileLactobacillus reuteriantimicrobial resistancenext-generation probioticsreuterin

More Related Videos

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.4K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

40.2K

Related Experiment Videos

Last Updated: Feb 25, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.3K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.4K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

40.2K

Area of Science:

  • Microbiology and Immunology
  • Gastroenterology
  • Pharmacology

Background:

  • Antimicrobial resistance necessitates novel therapeutic strategies for diseases like Clostridium difficile infection (CDI).
  • Next-generation probiotics are being developed to prevent CDI recurrence, requiring intrinsic antibiotic resistance.
  • Lactobacillus reuteri, a human-derived bacterium, converts glycerol into the antimicrobial compound reuterin.

Purpose of the Study:

  • To identify and characterize a probiotic effective against Clostridium difficile infection (CDI).
  • To investigate the potential of Lactobacillus reuteri as an adjunct therapy for CDI.
  • To explore the role of reuterin production by L. reuteri in combating CDI.

Main Methods:

  • Screening of bacterial species for intrinsic resistance to antibiotics used in CDI treatment.
  • Supplementation of Lactobacillus reuteri with glycerol to induce reuterin production.
  • In vitro and in vivo studies using human fecal microbial communities to assess efficacy against C. difficile.
  • Microbiome and metabolomics analysis to understand treatment-induced microbial community changes.

Main Results:

  • Lactobacillus reuteri 17938, when supplemented with glycerol, produced potent reuterin, inhibiting C. difficile growth.
  • Reuterin was identified as the key antimicrobial agent responsible for inhibiting C. difficile growth.
  • Co-delivery of L. reuteri and glycerol effectively combated C. difficile colonization in human fecal microbial communities.
  • Microbiome and metabolomics analyses confirmed that glycerol-enhanced L. reuteri selectively targeted C. difficile outgrowth.

Conclusions:

  • Antimicrobial resistance can be exploited in the natural design of probiotics for microbiome-based therapies.
  • Glycerol precursor-directed probiotic therapy with Lactobacillus reuteri shows promise for preventing C. difficile recurrence.
  • Substrate bioavailability and antimicrobial resistance are critical factors determining probiotic efficacy in clinical settings.